Koers Sensus Healthcare, Inc.
Aandelen
SRTS
US81728J1097
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,29 USD | +1,23% | -2,66% | +39,41% |
Omzet 2024 * | 26,3 mln. 24,69 mln. | Omzet 2025 * | 32,26 mln. 30,28 mln. | Marktkapitalisatie | 53,94 mln. 50,63 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - 0 | Nettowinst (verlies) 2025 * | 3 mln. 2,82 mln. | EV/omzet 2024 * | 2,05 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,67 x |
K/w-verhouding 2024 * |
73,1
x | K/w-verhouding 2025 * |
16,5
x | Werknemers | 35 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 76,13% |
Recentste transcriptie over Sensus Healthcare, Inc.
1 dag | +1,23% | ||
1 week | -2,66% | ||
Lopende maand | -13,42% | ||
1 maand | -14,55% | ||
3 maanden | +26,05% | ||
6 maanden | +40,00% | ||
Lopend jaar | +39,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Golin
FOU | Founder | 71 | 07-05-10 |
Joseph Sardano
CEO | Chief Executive Officer | 71 | 07-05-10 |
Javier Rampolla
DFI | Director of Finance/CFO | 52 | 01-01-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Sardano
CEO | Chief Executive Officer | 71 | 07-05-10 |
Anthony Petrelli
BRD | Director/Board Member | 71 | 21-07-16 |
John Heinrich
BRD | Director/Board Member | 77 | 01-02-12 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.15% | 29 M€ | -5,60% | ||
0.08% | 27 M€ | -5,75% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 3,29 | +1,23% | 93 323 |
18-04-24 | 3,25 | 0,00% | 35 445 |
17-04-24 | 3,25 | +1,56% | 111 727 |
16-04-24 | 3,2 | 0,00% | 83 213 |
15-04-24 | 3,2 | -5,33% | 193 154 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,41% | 53,94 mln. | |
-46,92% | 2,62 mld. | |
+7,27% | 1,7 mld. | |
-15,17% | 1,41 mld. | |
+18,55% | 1,16 mld. | |
-15,69% | 968 mln. | |
-24,43% | 865 mln. | |
-9,20% | 699 mln. | |
-17,12% | 690 mln. | |
+5,90% | 491 mln. |